Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
SITC 2021
NCCN 2021 Virtual Congress: Hematologic Malignancies
2021 Lynn Sage Breast Cancer Symposium
2021 ASTRO Annual Meeting
AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Topics
Advertisement
Solid Tumors
Bladder Cancer
Breast Cancer
CNS Cancers
Colorectal Cancer
Gastroesophageal Cancer
Gastrointestinal Cancer
Gynecologic Cancers
Head and Neck Cancer
Hepatobiliary Cancer
Kidney Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Thyroid Cancer
Neuroendocrine Tumors
Hematologic Malignancies
Leukemia
Lymphoma
Lymphoma (Curated)
Multiple Myeloma
Myelodysplastic Syndromes
Issues in Oncology
Cost of Care
Geriatric Oncology
Global Cancer Care
Health-Care Policy
Legislation
Survivorship
Genomics/Genetics
Immunotherapy
COVID-19
Supportive Care
Integrative Oncology
Pain Management
Palliative Care
Symptom Management
Advertisement
Advertisement
Dec
04
Today In Oncology
Eftilagimod Alpha Plus Paclitaxel May Improve Survival in HR-Positive, HER2-Negative Metastatic Breast Cancer AIPAC Trial
Study Examines Safety and Efficacy of Retifanlimab in Recurrent MSI-H/dMMR Endometrial Cancer
Sotigalimab Plus Nivolumab in Anti–PD-1/PD-L1–Refractory Melanoma
Vidutolimad Plus Pembrolizumab in PD-1 Refractory Melanoma
Novel Vaccine Platform Plus Pembrolizumab May Boost Immune Response in Advanced HCC
View More
Advertisement
